Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock (NCT05185492)
🩺 Plain-English Summary (8th-Grade Level)
This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.
Who can join: Review the eligibility criteria below.
Location: Cleveland Clinic Florida — Weston, Florida
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Cleveland Clinic Florida — Weston, Florida
- Inova Heart and Vascular Institute — Falls Church, Virginia
- University of Toronto — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (801) 585-2944
Email: john.kirk@hsc.utah.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiogenic Shock
- A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Boston, Massachusetts
- Augmented Pacing for Shock in the Cardiac Intensive Care Unit — Nashville, Tennessee
- Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock — Loma Linda, California
- CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock — Boston, Massachusetts
- Intra-aortic Balloon Counterpulsation (IABC) Compliance — Philadelphia, Pennsylvania
- Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial — Falls Church, Virginia
Explore by condition: All Cardiogenic Shock clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.